vs

Side-by-side financial comparison of Snail, Inc. (SNAL) and Xilio Therapeutics, Inc. (XLO). Click either name above to swap in a different company.

Snail, Inc. is the larger business by last-quarter revenue ($25.1M vs $13.7M, roughly 1.8× Xilio Therapeutics, Inc.). Xilio Therapeutics, Inc. runs the higher net margin — 75.7% vs -3.4%, a 79.1% gap on every dollar of revenue.

Suzhou Snail Digital Technology Co., Ltd., doing business as Snail, is a Chinese video game company and a Virtual Network Operator headquartered in Suzhou, China, which has branches Snail Games and Snail Mobile. Its division, Snail USA, markets Snail Games products in North America, South America, & Europe. Snail Games products include massively multiplayer online (MMOs), real-time strategy (RTS), and casual games. Its global registered user base has reached over 70 million accounts. The U.S....

Xilio Therapeutics is a clinical-stage biotechnology company dedicated to developing novel tumor-selective immunotherapies for cancer treatment. Its product pipeline features candidates engineered to trigger anti-tumor immune responses specifically inside tumor microenvironments, reducing systemic toxicities, and it primarily targets oncology patient populations in North America and other global markets.

SNAL vs XLO — Head-to-Head

Bigger by revenue
SNAL
SNAL
1.8× larger
SNAL
$25.1M
$13.7M
XLO
Higher net margin
XLO
XLO
79.1% more per $
XLO
75.7%
-3.4%
SNAL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
SNAL
SNAL
XLO
XLO
Revenue
$25.1M
$13.7M
Net Profit
$-862.2K
$10.4M
Gross Margin
38.3%
Operating Margin
-6.0%
-86.5%
Net Margin
-3.4%
75.7%
Revenue YoY
-4.2%
Net Profit YoY
-177.0%
179.1%
EPS (diluted)
$-3.74

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SNAL
SNAL
XLO
XLO
Q4 25
$25.1M
$13.7M
Q3 25
$13.8M
$19.1M
Q2 25
$22.2M
$8.1M
Q1 25
$20.1M
$2.9M
Q4 24
$26.2M
Q3 24
$22.5M
Q2 24
$21.6M
Q1 24
$14.1M
Net Profit
SNAL
SNAL
XLO
XLO
Q4 25
$-862.2K
$10.4M
Q3 25
$-7.9M
$-16.3M
Q2 25
$-16.6M
$-15.8M
Q1 25
$-1.9M
$-13.3M
Q4 24
$1.1M
Q3 24
$235.1K
Q2 24
$2.3M
Q1 24
$-1.8M
Gross Margin
SNAL
SNAL
XLO
XLO
Q4 25
38.3%
Q3 25
0.1%
Q2 25
31.3%
Q1 25
29.1%
Q4 24
43.3%
Q3 24
38.6%
Q2 24
37.5%
Q1 24
14.7%
Operating Margin
SNAL
SNAL
XLO
XLO
Q4 25
-6.0%
-86.5%
Q3 25
-71.3%
-10.1%
Q2 25
-8.2%
-177.7%
Q1 25
-20.4%
-472.7%
Q4 24
11.5%
Q3 24
1.8%
Q2 24
12.4%
Q1 24
-15.6%
Net Margin
SNAL
SNAL
XLO
XLO
Q4 25
-3.4%
75.7%
Q3 25
-56.9%
-85.4%
Q2 25
-74.7%
-196.0%
Q1 25
-9.7%
-452.7%
Q4 24
4.3%
Q3 24
1.0%
Q2 24
10.4%
Q1 24
-12.6%
EPS (diluted)
SNAL
SNAL
XLO
XLO
Q4 25
$-3.74
Q3 25
$-0.11
Q2 25
$-0.44
$-0.16
Q1 25
$-0.06
$-0.18
Q4 24
$0.03
Q3 24
$0.01
Q2 24
$0.06
Q1 24
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SNAL
SNAL
XLO
XLO
Cash + ST InvestmentsLiquidity on hand
$8.6M
$137.5M
Total DebtLower is stronger
$14.6M
Stockholders' EquityBook value
$-16.4M
$35.3M
Total Assets
$59.3M
$154.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SNAL
SNAL
XLO
XLO
Q4 25
$8.6M
$137.5M
Q3 25
$12.3M
$103.8M
Q2 25
$7.9M
$121.6M
Q1 25
$9.4M
$89.1M
Q4 24
$7.3M
Q3 24
$10.6M
Q2 24
$15.5M
Q1 24
$16.1M
Total Debt
SNAL
SNAL
XLO
XLO
Q4 25
$14.6M
Q3 25
$10.5M
Q2 25
$11.8M
Q1 25
$9.0M
Q4 24
$5.7M
Q3 24
$5.7M
Q2 24
$5.8M
Q1 24
$6.5M
Stockholders' Equity
SNAL
SNAL
XLO
XLO
Q4 25
$-16.4M
$35.3M
Q3 25
$-15.6M
$-8.1M
Q2 25
$-8.0M
$7.1M
Q1 25
$9.1M
$10.7M
Q4 24
$9.7M
Q3 24
$8.2M
Q2 24
$7.9M
Q1 24
$5.6M
Total Assets
SNAL
SNAL
XLO
XLO
Q4 25
$59.3M
$154.7M
Q3 25
$51.1M
$133.7M
Q2 25
$58.0M
$133.8M
Q1 25
$64.5M
$103.7M
Q4 24
$62.2M
Q3 24
$66.8M
Q2 24
$75.4M
Q1 24
$78.3M
Debt / Equity
SNAL
SNAL
XLO
XLO
Q4 25
Q3 25
Q2 25
Q1 25
0.99×
Q4 24
0.59×
Q3 24
0.70×
Q2 24
0.73×
Q1 24
1.16×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SNAL
SNAL
XLO
XLO
Operating Cash FlowLast quarter
$-5.3M
$-2.0M
Free Cash FlowOCF − Capex
$-2.1M
FCF MarginFCF / Revenue
-15.3%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
-0.19×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SNAL
SNAL
XLO
XLO
Q4 25
$-5.3M
$-2.0M
Q3 25
$6.6M
$-17.5M
Q2 25
$-3.2M
$-14.5M
Q1 25
$764.5K
$29.0M
Q4 24
$-3.6M
Q3 24
$-5.0M
Q2 24
$206.6K
Q1 24
$6.8M
Free Cash Flow
SNAL
SNAL
XLO
XLO
Q4 25
$-2.1M
Q3 25
Q2 25
$-14.9M
Q1 25
$29.0M
Q4 24
Q3 24
Q2 24
Q1 24
FCF Margin
SNAL
SNAL
XLO
XLO
Q4 25
-15.3%
Q3 25
Q2 25
-184.0%
Q1 25
988.3%
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
SNAL
SNAL
XLO
XLO
Q4 25
0.7%
Q3 25
0.0%
Q2 25
5.0%
Q1 25
0.8%
Q4 24
Q3 24
Q2 24
Q1 24
Cash Conversion
SNAL
SNAL
XLO
XLO
Q4 25
-0.19×
Q3 25
Q2 25
Q1 25
Q4 24
-3.21×
Q3 24
-21.05×
Q2 24
0.09×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SNAL
SNAL

Pc$14.7M59%
Platform Three$5.2M21%
Platform Two$3.3M13%
Sales Channel Directly To Consumer Mobile Sale$1.6M6%

XLO
XLO

Segment breakdown not available.

Related Comparisons